 |
 |
 |
Search Stock:
Bal Pharma Share Price, Technical, Fundamental Analysis, Financials, Shareholding, RSI, MACD and Moving Averages
Price on NSE
Price on BSE
Bal Pharma (BALPHARMA) Key Ratios
P/E
Company18.33
Sector6.39
A Price-to-Earnings of 18.33 means investors pay 18.33 units per 1 unit of earnings. This is higher than the sector average of 6.39.
P/B
Company1.62
Sector4.34
A P/B ratio of 1.62 shows market value relative to book value. This is lower than the sector average of 4.34.
ROA
Company1.93%
Sector-17.89%
Return on Assets shows a 1.93% profit per unit of asset. This is lower than the sector average of -17.89%.
ROE
Company7.64%
Sector-3.17%
Return on Equity creates 7.64% profit per unit of equity. This is higher than the sector average of -3.17%.
ROCE
Company9.18%
Sector6.29%
ROCE indicates 9.18% operating earnings per unit of capital. This is higher than the sector average of 6.29%.
EV/EBITDA
Company8.13
Sector14.79
EV/EBITDA of 8.13 means value is 8.13 times core earnings. This is lower than the sector average of 14.79.
Bal Pharma Share Price Analysis Local DB
Bal Pharma share price is ₹85.65, day high (share price) is ₹88.88, day low (share price) is ₹84.10 and volume is 14,659. 52 Week high share price for Bal Pharma is ₹98.85 on 27 May 2026 and 52 week low share price for Bal Pharma is ₹60.00 on 30 Mar 2026. Price data as of: 02 Sep, 2026 3:31 PM.
According to latest price data (as of 02 Sep, 2026 3:31 PM) for Bal Pharma share, 14 day period RSI (Relative Strength Index) is 48.9, 50 DMA (50 Displaced Moving Average) is 85.26 and 200 DMA (200 Displaced Moving Average) is 78.06.
▲
₹85.65
0.20 (0.23%)
As of 02 Sep, 2026
Open
₹84.10
Day High - Low
₹88.88 - ₹84.10
Volume
14,659
52 Weeks High
₹98.85
on 27 May 2026
52 Weeks Low
₹60.00
on 30 Mar 2026
RSI (14)
48.9
50 DMA
85.26
200 DMA
78.06
Loading...
Bal Pharma (BALPHARMA) Technical Analysis
₹85.65
+0.20
02 Sep, 2026
Bal Pharma Technical Data and Analysis available in multiple timeframes.
Bal Pharma Oscillators Analysis
On the Day timeframe, the outlook for BALPHARMA is: The long-term trend is Positive (Price vs 200 SMA) and RSI (14) is: 48.9.
Bal Pharma Price Action
Bal Pharma Oscillators Overview
| Indicator | Value |
|---|---|
| RSI (14) | 48.90 |
| Stoch %K (14, 3, 3) | 43.93 |
| CCI (20) | -18.33 |
| ADX (14) | 16.06 |
| Awesome Osc | -1.91 |
| Momentum (10) | 0.83 |
| MACD (12, 26, 9) | -0.44 |
| MACD Signal | -0.28 |
| Stoch RSI (14) | 59.61 |
| Williams %R (14) | -48.28 |
| Bull/Bear Power | 1.79 |
| Ultimate Osc | 35.04 |
| MFI (14) | 49.41 |
| ROC (21) | -2.53 |
| ROC (125) | 13.78 |
| ATR (14) | 3.25 |
Bal Pharma Moving Averages
BALPHARMA is trading above 9 out of 14 SMAs.
85.65
CURRENT PRICE
Bullish Moving Averages
9
Bearish Moving Averages
5
5 SMA85.18
8 SMA84.99
9 SMA85.09
10 SMA85.25
12 SMA85.22
20 SMA86.37
21 SMA86.50
26 SMA86.84
30 SMA86.99
34 SMA87.19
50 SMA85.26
100 SMA83.77
150 SMA79.52
200 SMA78.06
| Ichimoku Base | 87.53 | Below Base |
| VWMA (20) | 87.35 | Below VWMA |
| HMA (9) | 85.36 | Above HMA |
Bal Pharma Technical SWOT Analysis
STRENGTHS
- Price is trading above the 200 DMA, indicating relatively stronger long-term positioning.
- Price is above the 50 DMA, suggesting supportive medium-term trend structure.
WEAKNESSES
- MACD is below the signal line and in negative territory, reflecting downward momentum.
OPPORTUNITIES
- No specific opportunity signals are identified; the setup appears neutral.
THREATS
- No immediate technical risk signals are identified.
Bal Pharma Daily Pivot Points (Support & Resistance)
| Level | Classic | Woodie's | Camarilla | Fibonacci |
|---|---|---|---|---|
| Resistance 3 | 90.84 | 89.32 | 86.41 | 89.27 |
| Resistance 2 | 89.27 | 88.51 | 86.09 | 87.94 |
| Resistance 1 | 87.36 | 85.84 | 85.77 | 87.12 |
| Pivot Point | 85.79 | 85.03 | 85.45 | 85.79 |
| Support 1 | 83.88 | 82.36 | 85.13 | 84.46 |
| Support 2 | 82.31 | 81.55 | 84.81 | 83.64 |
| Support 3 | 80.40 | 78.88 | 84.49 | 82.31 |
Records:
| Date | Close | ADX | PDI | MDI | Aroon Up | Aroon Down | Bollinger UB | Bollinger MB | Bollinger LB | CCI | CMF | MACD | Signal | MFI | PSAR | RSI (F) | RSI | Sto (F) %K | %D | Supertrend | Ult Osc | Wil %R |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing oscillators history... | ||||||||||||||||||||||
Records:
| Date | Close | SMA(5) | EMA(5) | SMA(8) | EMA(8) | SMA(9) | EMA(9) | SMA(10) | EMA(10) | SMA(12) | EMA(12) | SMA(20) | EMA(20) | SMA(21) | EMA(21) | SMA(26) | EMA(26) | SMA(30) | EMA(30) | SMA(34) | EMA(34) | SMA(50) | EMA(50) | SMA(100) | EMA(100) | SMA(150) | EMA(150) | SMA(200) | EMA(200) | Ichimoku Base | VWMA(20) | HMA(9) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing moving averages history... | ||||||||||||||||||||||||||||||||
Bal Pharma - Shareholding Pattern
Historical breakdown of ownership percentages over time.
| Category | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 50.86% | 50.86% | 50.86% | 50.86% |
| FII | 0.15% | 0.14% | 0.14% | 0.22% |
| DII (Other) | 0.00% | 0.00% | 0.00% | 0.00% |
| Retail & Others | 48.99% | 49.01% | 49.01% | 48.92% |
| Mutual Funds | 0.00% | 0.00% | 0.00% | 0.00% |
Bal Pharma - Yearly Income Statement (in ₹ Crore)
| Period | Revenue | Operating Profit | Net Profit |
|---|---|---|---|
| Mar 2026 | 313.59 +2.72% | 5.93 +15.37% | 6.32 -12.71% |
| Mar 2025 | 305.28 -10.76% | 5.14 -43.2% | 7.24 -2.82% |
| Mar 2024 | 342.07 +12.08% | 9.05 +90.53% | 7.45 +184.35% |
| Mar 2023 | 305.20 | 4.75 | 2.62 |
Bal Pharma - Corporate Actions
| Type | Ex-Date | Amount / Ratio | Details |
|---|---|---|---|
| Dividend | 18 Sep 2025 | ₹1.2 | View Details |
|
Announcement date
29 May 2025
Ex dividend date
18 Sep 2025
Record date
18 Sep 2025
Dividend type
Final
Amount
1.2
Dividend %
12.0
Details
Rs.1.2000 per share(12%)Dividend
|
|||
Bal Pharma Share Price and Volume Historical Data
Synchronizing MarketBandhu Database...